Drug Transporter (DT) Information

General Information of DT
DT ID DTD0022
Gene Name SLC15A2
Protein Name Peptide transporter 2
Gene ID
6565
UniProt ID
Q16348
TCDB ID
2.A.17.4.8
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 2XUT_A

Identity: 30.7%

Minimized Score: -615.174 kcal/mol

Detail: Structure Info

Synonyms Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2
DT Family Proton-Dependent Oligopeptide Transporter (POT/PTR) Family ;
Tissue Specificity Expressed in kidney. Not detected inintestine.
Function This tranporter mediates intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides. Transports the dipeptide-like aminopeptidase inhibitor bestatin. Can also transport the aminocephalosporin antibiotic cefadroxil.
Disease(s) High blood pressure [ICD-11: BA00]
Peripheral T-cell lymphoma [ICD-11: 2A90.C]
Streptococcal pharyngitis [ICD-11: 1B51]
Shingles [ICD-11: 1.00E+91]
Endogenous Substrate(s) Peptides
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation
Mutation-induced Structural Variation (MSV)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:          23 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Aminolevulinic acid
 Approved Drug Info Photodynamic therapy EK90.0 [1]
Amoxicillin
 Approved Drug Info Streptococcal pharyngitis 1B51 [2]
Ampicillin
 Approved Drug Info Bacterial infections 1A00-1H0Z [3]
Benazepril
 Approved Drug Info High blood pressure BA00 [4]
Bestatin
 Approved Drug Info Acute myeloid leukemia 2A60 [5]
Cefaclor
 Approved Drug Info Gram-positive & negative bacteria infections 1A00-1H0Z [2]
Cefadroxil
 Approved Drug Info Gram-positive & negative bacteria infections 1A00-1H0Z [6]
Cefixime
 Approved Drug Info Streptococcus bacterial infections 1C41 [3]
Ceftibuten
 Approved Drug Info Chronic bronchitis CA20.1 [3]
Cephalexin
 Approved Drug Info Gram-positive bacteria infections 1A00-1H0Z [3]
Cephradine
 Approved Drug Info Streptococcus pneumoniae infections CA40.0Y [3]
Cyclacillin
 Approved Drug Info Bacterial infections 1A00-1H0Z [3]
Dicloxacillin
 Approved Drug Info Susceptible gram-positive bacteria infections 1A00-1H0Z [3]
Enalapril
 Approved Drug Info High blood pressure BA00 [7]
Entecavir
 Approved Drug Info Chronic hepatitis B infection 1E51.0 [8]
Fosinopril
 Approved Drug Info High blood pressure BA00 [9]
Moexipril
 Approved Drug Info High blood pressure BA00 [4]
Moxalactam
 Approved Drug Info Bacterial infections 1A00-1H0Z [3]
Perindopril
 Approved Drug Info High blood pressure BA00 [4]
Ramipril
 Approved Drug Info High blood pressure BA00 [4]
Spirapril
 Approved Drug Info High blood pressure BA00 [4]
Trandolapril
 Approved Drug Info High blood pressure BA00 [4]
Valacyclovir
 Approved Drug Info Shingles 1.00E+91 [10]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Metampicillin
 Preclinical Drug Info Bacterial infections 1A00-1H0Z [3]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            4 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Aminolevulinic acid Approved Drug Info Oocytes-PEPT2 Km = 227 microM [11]
Amoxicillin Approved Drug Info Madin-Darby canine kidney (MDCK) cells-PEPT2 Km = 1040 microM [2]
Cefaclor Approved Drug Info Madin-Darby canine kidney (MDCK) cells-PEPT2 Km = 72 microM [2]
Cefadroxil Approved Drug Info In vivo model (human) Km = 150.8 microM [6]
References
1 PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res. 2006 Nov 29;1122(1):18-23.
2 Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters. Drug Metab Dispos. 2006 Apr;34(4):547-55.
3 Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60.
4 Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. J Pharmacol Exp Ther. 2008 Nov;327(2):432-41.
5 Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2. Am J Physiol Renal Physiol. 2008 Jun;294(6):F1422-32.
6 Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants. Drug Metab Dispos. 2017 Feb;45(2):130-136.
7 Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes. Alcohol Clin Exp Res. 2008 May;32(5):777-84.
8 The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney. Eur J Pharm Sci. 2014 Feb 14;52:41-7.
9 Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures. Drug Metab Dispos. 2001 Oct;29(10):1307-15.
10 Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun. 1998 May 19;246(2):470-5.
11 Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest. 1998 Jun 15;101(12):2761-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.